Colin R. Goding

16.4k total citations · 2 hit papers
153 papers, 11.7k citations indexed

About

Colin R. Goding is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Colin R. Goding has authored 153 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Molecular Biology, 62 papers in Cell Biology and 31 papers in Immunology. Recurrent topics in Colin R. Goding's work include melanin and skin pigmentation (52 papers), Genomics and Chromatin Dynamics (27 papers) and Melanoma and MAPK Pathways (21 papers). Colin R. Goding is often cited by papers focused on melanin and skin pigmentation (52 papers), Genomics and Chromatin Dynamics (27 papers) and Melanoma and MAPK Pathways (21 papers). Colin R. Goding collaborates with scholars based in United Kingdom, United States and France. Colin R. Goding's co-authors include Suzanne Carreira, Peter O’Hare, Keith S. Hoek, F. Fisher, Jane Goodall, Keith W. Vance, Ugur Yavuzer, Lionel Larue, Timothy Eisen and Heinz Arnheiter and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Colin R. Goding

151 papers receiving 11.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma

2014 427 citations Colin R. Goding et al. Nature Communications profile →
Sublethal cytochrome c release generates drug-tolerant persister cells

2022 138 citations Colin R. Goding et al. profile →

Peers

Countries citing papers authored by Colin R. Goding

Since Specialization

Citations

This map shows the geographic impact of Colin R. Goding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin R. Goding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin R. Goding more than expected).

Fields of papers citing papers by Colin R. Goding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin R. Goding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin R. Goding. The network helps show where Colin R. Goding may publish in the future.

Co-authorship network of co-authors of Colin R. Goding

This figure shows the co-authorship network connecting the top 25 collaborators of Colin R. Goding. A scholar is included among the top collaborators of Colin R. Goding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin R. Goding. Colin R. Goding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State 2024 ·Pigment Cell & Melanoma Research ·(unknown), Yilun Ma, Pakavarin Louphrasitthiphol, (unknown), Miranda V. Hunter, (unknown), Henrik Molina, Colin R. Goding, Richard M. White	5
2	DNA damage remodels the MITF interactome to increase melanoma genomic instability 2024 ·Genes & Development ·(unknown), Jean‐Philippe Lambert, Markéta Tomková, (unknown), Arianna Baggiolini, S. Picaud, Sovan Sarkar, Pakavarin Louphrasitthiphol, (unknown), Suzanne Carreira, Timothy C. Humphrey, (unknown), Richard M. White, Colin R. Goding	4
3	Stem cell heterogeneity, plasticity, and regulation 2023 ·Life Sciences ·Ziyang Cui, (unknown), Colin R. Goding, Rutao Cui	9
4	Single‐cell profiling of MC1R‐inhibited melanocytes 2023 ·Pigment Cell & Melanoma Research ·(unknown), Dawn E. Watkins‐Chow, (unknown), Pakavarin Louphrasitthiphol, Tongwu Zhang, Kevin M. Brown, Pedro Moura‐Alves, Colin R. Goding, William J. Pavan	3
5	Acetylation reprograms MITF target selectivity and residence time 2023 ·Nature Communications ·Pakavarin Louphrasitthiphol, Alessia Loffreda, Vivian Pogenberg, S. Picaud, Alexander Schepsky, Hans Friedrichsen, Zhiqiang Zeng, Anahita Lashgari, Benjamin Thomas, E. Elizabeth Patton, Matthias Wilmanns, P. Filippakopoulos, Jean‐Philippe Lambert, Eirı́kur Steingrı́msson, Davide Mazza, Colin R. Goding	10
6	AMPK Phosphorylates ZDHHC13 to Increase MC1R Activity and Suppress Melanomagenesis 2023 ·Cancer Research ·Yu Sun, Xin Li, Chengqian Yin, (unknown), (unknown), Xianfang Wu, Ying Ni, Joshua Arbesman, Colin R. Goding, Shuyang Chen	17
7	Reciprocal Regulation of BRN2 and NOTCH1/2 Signaling Synergistically Drives Melanoma Cell Migration and Invasion 2021 ·Journal of Investigative Dermatology ·Mitchell E. Fane, Yash Chhabra, Loredana Spoerri, Jacinta L. Simmons, R Ludwig, Elise Bonvin, Colin R. Goding, Richard A. Sturm, Glen M. Boyle, Nikolas K. Haass, Michael Piper, Aaron G. Smith	3
8	TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITF 2021 ·Journal of Investigative Dermatology ·Jade Peres, Victoria Damerell, Jagat Chauhan, (unknown), Pierre‐Yves Desprez, Marie‐Dominique Galibert, Colin R. Goding, Sharon Prince	7
9	The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor 2019 ·PLoS Genetics ·(unknown), Jennifer Y. Tan, Michael Shapiro, Pakavarin Louphrasitthiphol, Andrew Bassett, Ana Claudia Marques, Colin R. Goding, Keith W. Vance	53
10	Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngioma 2017 ·Nature Communications ·José Mario González-Meljem, Scott Haston, Gabriela Carreno, John Apps, Sara Pozzi, Christina Stache, (unknown), Alex Virasami, Leonidas Panousopoulos, (unknown), Ana Guerrero, Mamunur Rashid, (unknown), Colin R. Goding, Thomas S. Jacques, David J. Adams, Jesús Gil, Cynthia L. Andoniadou, Juan Pedro Martı́nez-Barberá	84
11	MITF is a critical regulator of the carcinoembryonic antigen‐related cell adhesion molecule 1 (CEACAM1) in malignant melanoma 2015 ·Pigment Cell & Melanoma Research ·Nico Ullrich, Stefanie Löffek, Susanne Horn, (unknown), Luís Sánchez‐del‐Campo, Fang Zhao, Frank Breitenbuecher, Irwin Davidson, Bernhard B. Singer, Dirk Schadendorf, Colin R. Goding, Iris Helfrich	8
12	MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment 2015 ·Nature Communications ·Stefanie Riesenberg, (unknown), Robert Siddaway, Tobias Bald, Julia Reinhardt, (unknown), Judith Kohlmeyer, Marcel Renn, Bengt Phung, (unknown), Tobias Schmidt, Veit Hornung, Irwin Davidson, Colin R. Goding, Göran Jönsson, Jennifer Landsberg, Thomas Tüting, Michael Hölzel	153
13	Intravital Imaging Reveals Transient Changes in Pigment Production and Brn2 Expression during Metastatic Melanoma Dissemination 2009 ·Cancer Research ·Sophie Pinner, Peter Jordan, Kirsty Sharrock, Laura Bazley, Lucy Collinson, Richard Marais, Elise Bonvin, Colin R. Goding, Erik Sahai	160
14	T‐box factors: targeting to chromatin and interaction with the histone H3 N‐terminal tail 2007 ·Pigment Cell Research ·Florence Demay, (unknown), Mercedes Rodríguez, Suzanne Carreira, (unknown), (unknown), Colin R. Goding	23
15	The Brn-2 Transcription Factor Links Activated BRAF to Melanoma Proliferation 2004 ·Molecular and Cellular Biology ·Jane Goodall, Claudia Wellbrock, (unknown), Karen Roberts, Richard Marais, Colin R. Goding	90
16	Targeting the Microphthalmia Basic Helix-Loop-Helix–Leucine Zipper Transcription Factor to a Subset of E-Box Elements In Vitro and In Vivo 1998 ·Molecular and Cellular Biology ·Isil Aksan, Colin R. Goding	176
17	Regulation of melanocyte differentiation and growth. 1997 ·PubMed ·Colin R. Goding, David E. Fisher	14
18	Melanocyte-Specific Gene Expression: Role of Repression and Identification of a Melanocyte-Specific Factor, MSF 1994 ·Molecular and Cellular Biology ·Ugur Yavuzer, Colin R. Goding	11
19	Positive and Negative Elements Regulate a Melanocyte-Specific Promoter 1992 ·Molecular and Cellular Biology ·(unknown), Ugur Yavuzer, Colin R. Goding	12
20	An ATF/CREB binding motif is required for aberrant constitutive expression of the MHC class II DRα promoter and activation by SV4O T-antigen 1992 ·Nucleic Acids Research ·P. Cox, Colin R. Goding	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact